885 results on '"Talbot K"'
Search Results
152. 1118 Are MND patients pre-morbidly fitter? Indirect evidence from hospital record-linkage
153. 169 Antisaccade task as a biomarker in MND
154. New Developments in Australian Coal Production
155. Familial versus sporadic amyotrophic lateral sclerosis--a false dichotomy?
156. S.I.2 Motor neuron disorders and vulnerability to RNA processing
157. 063 Acceleration of fibrinolysis by factor xa-antithrombin complex
158. O16 Mouse models of SMA: implications for the timing and delivery of therapy
159. Heterotopic pregnancy
160. G.O.26 - Development of LNA gapmer oligonucleotide based therapy for FTD/ALS caused by the C9orf72 repeat expansion
161. Do twin studies still have anything to teach us about the genetics of amyotrophic lateral sclerosis?
162. POMD09 Understanding the early pathological pathways in Parkinson's disease. The Oxford Parkinson's Disease Centre
163. PATH44 Corpus callosum diffusion tensor imaging as a biomarker for motor neurone disease
164. PORT02 Oxford motor neurone disorders research
165. POD12 Development of a hands-free, eye-tracking version of the Trail Making Test
166. PATU5 Characterisation of fused in sarcoma pathology and FUS mutations in juvenile amyotrophic lateral sclerosis with basophilic inclusions
167. Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis
168. P89 An MRI biomarker for motor neuron disease?
169. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice
170. Motor neuron disease: THE BARE ESSENTIALS
171. Another gene for ALS: Mutations in sporadic cases and the rare variant hypothesis
172. Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression
173. Progressive unsteadiness in a 68-year-old man with longstanding abdominal pain and altered bowel habit
174. Functional vitamin B12 deficiency
175. Amyotrophic lateral sclerosis, 2d ed
176. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS
177. Candidate screening of the bovine and feline spinal muscular atrophy genes reveals no evidence for involvement in human motor neuron disorders
178. Temporal Expression of N-methyl-D-aspartate R1 (NR1) Subunit of the NMDA Glutamate Receptor in Mouse Models of Rett Syndrome
179. Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1
180. The study of rare diseases: butterfly collecting or an entree to understanding common conditions?
181. Genetics of sporadic amyotrophic lateral sclerosis
182. Impressions of ophthalmology in London
183. Electron beam compression with electric and magnetic fields
184. Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome
185. Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene
186. Sensitization by blood transfusion results in antibody production that correlates with C4d deposition and rejection
187. Pretransplant donor-specific transfusion accelerates complement-dependent cardiac allograft dysfunction
188. Vitamin E deficiency induced neurological disease in common variable immunodeficiency: two cases and a review of the literature of vitamin E deficiency
189. PREGNANCY-INDUCED SENSITIZATION AND CARDIAC ALLOGRAFT INJURY: ROLE OF HUMORAL IMMUNITY
190. Musculoskeletal diseases: from complex genetics to therapy
191. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy
192. Genomic organization and chromosomal localization of a member of the MAP kinase phosphatase gene family to human chromosome 11p15.5 and a pseudogene to 10q11.2.
193. Accelerated cardiac allograft rejection with apoptosis and complement deposition in Fc receptor null mice
194. Genomic Organization and Chromosomal Localization of a Member of the MAP Kinase Phosphatase Gene Family to Human Chromosome 11p15.5 and a Pseudogene to 10q11.2
195. Gene conversion at the SMN locus in autosomal recessive spinal muscular atrophy does not predict a mild phenotype
196. Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism?
197. Evidence for compound heterozygosity causing mild and severe forms of autosomal recessive spinal muscular atrophy.
198. Gene deletions in spinal muscular atrophy.
199. Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy
200. Vasoactive intestinal peptide, but not pituitary adenylate cyclase-activating peptide, modulates the responsiveness of the gonadotroph to LHRH in man
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.